FDA acknowledges slow response, 'suboptimal' decisions leading up to infant formula shortage
WASHINGTON — Sluggish response and questionable decisions by the Food and Drug Administration exacerbated the nation's infant formula shortage, agency officials told lawmakers at a congressional hearing on Wednesday. "You're right to be concerned, and the public should be concerned," said FDA Commissioner Robert Califf. The agency's response "was too slow and there were decisions that were ...
by Anumita Kaur, Los Angeles Times
May 25, 2022
2 minutes
![](https://article-imgs.scribdassets.com/1fi1qhs2io9tp72d/images/filePWAT2D2H.jpg)
WASHINGTON — Sluggish response and questionable decisions by the Food and Drug Administration exacerbated the nation's infant formula shortage, agency officials told lawmakers at a congressional hearing on Wednesday.
"You're right to be concerned, and the public should be concerned," said FDA Commissioner Robert Califf. The agency's response "was too slow and there were decisions that were suboptimal along the way."
You’re reading a preview, subscribe to read more.
Start your free 30 days